Yurong Guo
Senior Director, ADQC Arcturus Therapeutics
Seminars
Wednesday 25th February 2026
Roundtable Discussion: Translating Complex mRNA Characterization Assays into QC-Ready Strategies to Reduce Downtime between Teams
9:30 am
- How to adapt AD assays into validated QC workflows to ensure reproducibility across sites and manufacturing scales
- How to overcome challenges of assay transfer, variability, and lack of reference standards to safeguard consistency and compliance
- How to embed standardized characterization workflows to support smoother regulatory submissions, tech transfer and global comparability
Thursday 26th February 2026
Measuring Replication Competence, Integrity & dsRNA in saRNA to Strengthen Potency, Reduce Immunogenicity & Build Regulatory Confidence
12:00 pm
- Characterizing saRNA replication intermediates and byproducts to understand their impact on potency and safety
- Developing sensitive assays to monitor integrity and control dsRNA levels to reduce unwanted immunogenicity
- Translating early saRNA assays into QC-ready methods to build regulator confidence in this emerging modality
